Lynx2Market

22/03/2023

is built around 1-2-1 meetings that connect global pharma BD & Licensing professionals, empowered further by the content-driven program. The event showcases pharma opportunities for internationalization, in/out-licensing, investment, and portfolio development.

We are committed to reaching out to the broader BD & L community across the globe and hope that by bringing together like-minded people, we are helping to create connections that are truly beneficial to you.

Our portfolio of events covers the following:

event: Primary, Rx, Niche generics, and VAMs
: an event that is fully dedicated to Biosimilar medicines
-OTC: an event with a focus on OTC & CHC.

22/03/2023

“Cough & cold” and “Calm & Sleep” were the winners of the post-pandemic and gave a great boost to the / -focused companies.

Question: What will be the in the upcoming years? What will be the “next melatonin”?

is taking place on September 14-15 in Milan gathering / focused companies for and connecting & https://lnkd.in/es8BNiwg

Success Formula:
· : Mid-size / focused companies with to their product portfolios + from around the globe to forge & partnering
· : outlook of prospect & , stimulating discussions and showcases of the to boost / -focused companies

Join here: https://lnkd.in/es8BNiwg



&
/

01/08/2022

CALL FOR & & – arrange for at Autumn, September 15-16.

We welcome newly joined Unither Pharmaceuticals, BMG Pharma, Difass International, Zur Rose Group and MENARINI Group who have just confirmed their presence at Autumn, September 15-16.

Success Formula:
· : / focused companies with to their products + from around the globe to forge & deals
· : a pitch of driving consumer’s choice + of prospect geos

How to join? Click here – Autumn – PharmaSynergy (https://lnkd.in/gqDq_Bm
) or drop a note to [email protected]

***Fun fact 2: The most expensive drug costs more than $70,000. Myalept, a drug meant to treat a rare orphan disease, costs $71,306. It is used to treat a very rare condition called generalized lipodystrophy in which abnormal fat is distributed throughout the body. Myalept is the only drug available to treat this disease. People with the condition self-administer the drug once a day, using about 14 vials a month. Each vial costs about $5,000. (source: Rxinsider)

23/12/2021

28/10/2021

PharmaSynergy, September 22-23, 2021, Berlin & online - our first hybrid edition which is both in-person and online!
BD&Licensing partnering for companies focused on , and

02/08/2021

A group of mostly smaller countries submitted new, more ambitious climate pledges to the United Nations this week, raising pressure on big emitters including China to do the same ahead of a major U.N. climate summit in November.